Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Retreat In World Oil Price Flattens London Equities

Wed, 04th Feb 2015 17:42

LONDON (Alliance News) - London stock prices ended flat Wednesday, weighed down by energy-related shares, after a slide in the price of oil offset a positive UK economic reading and the decision by China's central bank to cut its reserve ratio for banks.

The FTSE 100 ended down 0.2% at 6,860.02, the FTSE 250 finished flat at 16,571.64, while the AIM All-Share closed up 0.1% at 694.03.

At the UK equities close, Brent oil was priced at USD55.92 a barrel, reversing an earlier gain to USD58.01, though still well clear of the USD50 mark. The US Energy Information Administration said Wednesday that US crude oil stocks rose by 6.3 million barrels to 413.1 million barrels in the week ended January 30, up 1.6% on the week and 15% year on year.

"As declines set in, Brent crude had managed to remain above USD56 per barrel after investors were unwilling to push the commodity’s levels any higher," said Spreadex analyst Connor Campbell. "However, Brent shot down to USD55 per barrel as the latest high US crude oil figure saw an increase of 6.3 million barrels, following 8.9 and 10.1 million in the last two weeks."

In the FTSE 100, Tullow Oil ended down 5.2%, BP down 1.6%, Royal Dutch Shell 'B' down 1.8% and 'A' down 1.1%, and BG Group down 1.4%, all among the index's worst performers.

In the FTSE 250, Afren fell 6.3%, Premier Oil 5.8%, Hunting 4.7%, John Wood Group 3.7%, Petrofac 2.2%, and Ophir Energy 2.1%.

The UK service sector began the year strongly, according to the Markit Services Purchasing Managers' Index. The index for January came in at 57.2, ahead of the 56.3 reading expected by economists and the 55.8 level in December.

The pound rose following the PMI data and was quoted at the UK equities close at USD1.5206.

Meanwhile, the eurozone private sector was reported to have expanded in January at the fastest pace since July last year as output expanded in Germany, Italy and Spain. But the downturn in the French economy extended into its ninth month. The final eurozone composite output index rose to 52.6 in January from 51.4 in December. It also improved upon the flash reading of 52.2.

European stocks closed mixed, with the CAC 40 in Paris down 0.4%, and the DAX 30 in Frankfurt up 0.2%.

The focus in Europe remained on Greece as Finance Minister Yanis Varoufakis continued his tour of European capitals to drum up support for changes to the country's debt programme.

"Germany said it is completely unwilling to tolerate a debt haircut, and is seeking a comment from Greece stating it will drop its pre-election promises. Greek Finance Minister Varoufakis is having a tougher time winning allies, not a great sign ahead of his meeting with staunch debt-cut opposition Wolfgang Schauble tomorrow," Spreadex's Campbell said.

Varoufakis said he would meet German Finance Minister Wolfgang Schaeuble on Thursday - correcting impressions that his tour of capitals was going to skip Berlin in an apparent snub to Europe's paymaster.

In the US, data showed that private sector jobs growth in the US fell short of expectations in January. Report released by payroll processor ADP showed that private sector employment increased by 213,000 jobs in January following an upwardly revised increase of 253,000 jobs in December.

The US non-manufacturing ISM purchase managers' index remained flat in January at 56.7, slightly above 56.3 economists forecasts, and also above the previous reading of 56.2 in December.

"The ISM report suggested that the US economy is heading in the right direction, but that there are concerns over the country’s job figures. Its unemployment claims tomorrow will give a better indication of this trend ahead of the all-important non-farm data on Friday," Campbell said.

The US reports initial and continuing jobless claim at 1330 GMT on Thursday, followed by non-farm payrolls at the same time on Friday.

The US service sector growth remained solid in January, according to a report from Markit on Wednesday. The services PMI index for January came in at 54.2, slightly above the flash reading of 54.0. The composite index also improved upon the flash reading at 54.4 versus 54.2.

At the London equities close, Wall Street was trading flat to higher. The DJIA was up 0.4%, while the S&P 500 was flat and the Nasdaq Composite was up 0.1%.

In China, the People's Bank of China reduced the reserve requirement ratio of banks by 0.5 percentage point to 19.5% with effect from February 5. This gave London's mining stocks a small boost during the morning, with Fresnillo closing up 0.9%.

ARM Holdings closed up 3.1% as the best performer in FTSE 100. The chip designer announced Tuesday a new suite of intellectual properties that are expected to be launched on mobile devices in 2016, including its ARM Cortex-A72 processor. The group said that in target configurations, the new processor well deliver CPU performance that is 50 times that of leading smartphones from five years ago.

In addition, Sony, one of ARM's main customers, raised its guidance for its full year, forecasting a smaller than initially expected loss. The Japanese company's provisional results showed stronger than expected revenue growth.

Also in the FTSE 100, Sky ended up 1.3%. The broadcaster posted a big increase in pretax profit for the first half of its financial year, boosted by a rise in revenue and exceptional gains from the sale of its stakes in ITV, which was the best FTSE 100 performer, up 2.9%, and the National Geographic Channel.

In its first results incorporating its acquisitions of Sky Italia and a majority stake in Sky Deutschland, Sky posted a pretax profit of GBP1.21 billion for the half year to end-December, compared with GBP507 million a year before, as revenue rose to GBP4.30 billion from GBP3.67 billion.

GlaxoSmithKline also ended among the best blue-chip performers, up 1.6%. The company reported a drop in pretax profit for 2014, hit by lower revenue for asthma and chronic obstructive pulmonary disease treatment Advair, and said that it was continuing to evaluate the possibility of an initial public offering for a minority stake in its HIV joint venture ViiV Healthcare.

The company sweetened the news for shareholders by raising its total dividend to 80 pence from 78 pence a year before, pledging to maintain this dividend level for 2015, and reiterating plans to return GBP4 billion of net proceeds from its transaction with Novartis to shareholders in 2015.

Also connected to the Novartis deal, Glaxo said separately near the close of trading that it is selling its 7.9% stake in Danish biotechnology company Genmab A/S via a share placing. GlaxoSmithKline currently holds 4.47 million shares in Copenhagen-listed Genmab. The stock closed Wednesday at DKK471.00, making Glaxo's stake worth DKK2.11 billion or GBP212.4 million.

Hargreaves Lansdown, down 8.5%, finished as the worst performer in the FTSE 100. The investment management product provider reported a drop in first-half pretax profit despite a rise in assets under administration over the course of the six months, in what was described as a "muted" time for stocks and retail investors.

In the economic calendar Thursday, German factory orders are due at 0700 GMT, followed by Bank Of England interest rate decision at 1200 GMT.

In the corporate calendar, Vodafone Group will provide an interim management statement, as will as Compass Group and Enterprise Inns. AstraZeneca and Smith & Nephew will release full-year results, and easyJet will publish its January Traffic Statistics.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.